Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pharma layoffs keep coming, but trail last year
Pharmalot
Wednesday, August 31, 2011 - 10:47am
tags:
layoffs
Data on Astra's Crestor drug vs Lipitor seen soon
Reuters
Wednesday, August 31, 2011 - 9:45am
tags:
AstraZeneca, Crestor, Lipitor, statins, Pfizer
Arena's experimental obesity drug lorcaserin beats placebo again
Yahoo/Reuters
Wednesday, August 31, 2011 - 9:43am
tags:
Arena, obesity, lorcaserin
Smith & Nephew Climbs in London as U.K. Newspapers Report Bid Speculation
Bloomberg
Wednesday, August 31, 2011 - 9:37am
tags:
Smith & Nephew, M&A
Off-Label Avastin Injections Linked To Blindness
Pharmalot
Wednesday, August 31, 2011 - 9:31am
tags:
off-label, blindness, Avastin, Genentech, Roche
Analyst says Human Genome's lupus treatment Benlysta receiving lukewarm reception from doctors
Yahoo/AP
Wednesday, August 31, 2011 - 9:27am
tags:
lupus, Benlysta, Human Genome Sciences
Aeterna Zentaris Passes Its Test
Motley Fool
Wednesday, August 31, 2011 - 9:20am
tags:
Aeterna Zentaris, AEZS-130, AGHD
Summary Box: Pfizer's new lung cancer drug
Yahoo/AP
Tuesday, August 30, 2011 - 7:08pm
tags:
lung cancer, Pfizer, Xalkori
The Mystery of BioMarin
Minyanville
Tuesday, August 30, 2011 - 7:05pm
tags:
Biomarin
UK's biotech stars may be fading, but new hopefuls shine
Fierce Biotech
Tuesday, August 30, 2011 - 12:17pm
tags:
UK, biotech
Why Docs Are Skittish About Prescribing Provenge
Pharmalot
Tuesday, August 30, 2011 - 11:37am
tags:
Provenge, physicians, prostate cancer, Dendreon
Salix Pharma Says FDA Accepts SNDA Filing For RELISTOR For Non-Cancer Pain
RTT News
Tuesday, August 30, 2011 - 11:34am
tags:
Relistor, Salix, FDA, painkiller
Teva Gains to 4-Week High After U.S. Court Denies Motion
Bloomberg
Tuesday, August 30, 2011 - 11:33am
tags:
Teva Pharmaceuticals, patents, Copaxone, Mylan, MS, multiple sclerosis
Qiagen Closes Cellestis Acquisition
Yahoo/Zacks.com
Tuesday, August 30, 2011 - 11:04am
tags:
Qiagen, Cellestis, M&A, Life Technologies
Astellas clot drug raises bleeding in heart study
Reuters
Tuesday, August 30, 2011 - 9:44am
tags:
Astellas, anticoagulants, Darexaban
FDA wants risk-based, centralized trial monitoring
Outsourcing Pharma
Tuesday, August 30, 2011 - 8:38am
tags:
FDA, clinical trials
10 Biotech Stocks Being Dumped By Big Money Managers
Seeking Alpha
Tuesday, August 30, 2011 - 8:36am
tags:
Acorda Therapeutics, Albany Molecular Research, Arena Pharmaceuticals, Dyax, Cephalon, Charles River Laboratories, Nektar, Questcor Pharmaceuticals, Vanda, QLT
NuPathe: FDA wants more data on migraine patch
Marketwatch
Tuesday, August 30, 2011 - 8:34am
tags:
FDA, migraines, migraine patch, NuPathe, Zelrix
Human Genome Sciences: A Buy For High-Risk Takers
Seeking Alpha
Monday, August 29, 2011 - 5:45pm
tags:
Human Genome Sciences
Time To Take A Second Look At Big Pharma
Seeking Alpha
Monday, August 29, 2011 - 5:44pm
tags:
Abbott Laboratories, Bristol-Myers Squibb, Merck, Eli Lilly, Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.